ArticleBioactive materials2026
Intelligent-responsive hydrogel synergistically mediates immune remodel-antibacterial-angiogenesis cascade for diabetic foot ulcer repair.
Article in Bioactive materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Biomaterial-based extracellular vesicle delivery systems for wound healing: From fabrication to applications.Bioactive materials · 2026Review
- Chitosan-Based Wound Dressings: Property Modulation, Fabrication Strategies, and Emerging Applications in Tissue Regeneration.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The healing of diabetic foot ulcers (DFU) is severely hindered by dysregulated immune microenvironment, recurrent infections, and insufficient angiogenesis. The persistent and resistant nature, coupled with elevated morbidity and amputation rates, has driven the scientific community to pursue the development of novel therapies. Current wound dressings mostly target a singular aspect and fail to achieve systematic regulation of these dynamically related factors, highlighting the urgent need for dressings capable of accurate sense and response to the complex pathological process of wound and precise repair. Herein, an intelligent treatment strategy of "intelligent response - synergistic regulation" was proposed. We designed a desferrioxamine-loaded Mn-doped zeolitic imidazolate framework-8 (DFO@Mn-ZIF-8), which exhibits dual enzyme-mimetic activity to scavenge excess reactive oxygen species (ROS) and, upon disintegration, combats infection and promotes angiogenesis. Subsequently, a glucose- and ROS-responsive chitosan-based hydrogel loaded with DFO@Mn-ZIF-8 and umbilical cord mesenchymal stem cell-derived exosome was fabricated (Exo/MOF@CPH). In a validated
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.